SGH
HOLX

Sivik Global Healthcare’s Hologic HOLX Stock Holding History

Sivik Global Healthcare’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-40,000
Closed -$3.06M – 55
2021
Q4 		$3.06M Sell
40,000
-20,000
-33% -$1.47M 1.31% 36
2021
Q3 		$4.43M Buy
60,000
+10,000
+20% +$750K 1.06% 35
2021
Q2 		$3.34M Buy
+50,000
New +$3.34M 0.65% 38
2020
Q3 		– Sell
-100,000
Closed -$5.7M – 51
2020
Q2 		$5.7M Buy
+100,000
New +$4.91M 1.89% 22
2017
Q1 		– Sell
-40,000
Closed -$1.6M – 62
2016
Q4 		$1.6M Buy
+40,000
New +$1.54M 0.77% 43

Other funds holding HOLX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Sivik Global Healthcare's HOLX Position: Q1 2022 in Review

Sivik Global Healthcare sold out of Hologic (HOLX) in Q1 2022, closing a stake of 40,000 shares — an estimated $3.06M sold.

Sivik Global Healthcare first reported a position in HOLX in Q4 2016 and held it in 5 quarters. The position peaked at $5.7M in Q2 2020. 700 funds tracked by Wall St. Rank hold HOLX as of Q1 2022.

  • Sivik Global Healthcare reported no remaining Hologic position as of Q1 2022 after selling out during the quarter.
  • Sivik Global Healthcare sold 40,000 Hologic shares in Q1 2022, an estimated $3.06M.
  • Sivik Global Healthcare first reported a position in Hologic in Q4 2016 and held it in 5 quarters.
  • Sivik Global Healthcare's Hologic position peaked at $5.7M in Q2 2020.
  • 700 funds tracked by Wall St. Rank held Hologic as of Q1 2022.

Based on Sivik Global Healthcare's 13F filing for Q1 2022, filed 9 May 2022.